Urinary tract infections
Low blood sugar (hypoglycemia)
Increased urination
Genital mycotic infections
Nausea
Metformin + Remogliflozin Etabonate is an antidiabetic combination.
Metformin is a biguanide. It works by reducing the production of glucose in your liver, slowing down glucose absorption from your intestines, and improving your body's sensitivity to insulin. These actions help to decrease the amount of sugar in your blood.
Remogliflozin Etabonate is an SGLT2 inhibitor. It operates by blocking the sodium-glucose co-transporter 2 (SGLT2) in your kidneys, which normally reabsorbs glucose back into your blood. By inhibiting this co-transporter, more glucose is excreted through your urine, thereby reducing the amount of sugar in your blood.
Doctor of Medicine
BMS, FMC, MD Resident
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any symptoms, please consult your doctor.
Frequently asked questions
Metformin + Remogliflozin Etabonate is a combination of two antidiabetic medicines which work together to control blood glucose levels in the body. Metformin reduces glucose production in the liver and increases the body's sensitivity to insulin, while Remogliflozin Etabonate inhibits glucose reabsorption in the kidneys.
No, Metformin + Remogliflozin Etabonate is not recommended for patients with type 1 diabetes. It is only used to manage type 2 diabetes.
Yes, this medicine should not be taken by patients with severe kidney impairment or end-stage renal disease, acute or chronic metabolic acidosis, including lactic acidosis, or those with known hypersensitivity to either Metformin or Remogliflozin Etabonate.
Some common side effects include genital mycotic infections, urinary tract infections, hypoglycemia (low blood sugar), nausea, and increased urination.
Yes, it can interact with several other medicines. It is important to inform your doctor about all the medications you are taking to check for potential interactions.
The use of Metformin + Remogliflozin Etabonate during pregnancy should only be considered if the potential benefit justifies the possible risk to the foetus. Always consult your doctor for individual advice.
Metformin + Remogliflozin Etabonate is not recommended for patients with hepatic impairment. Consult your doctor for more information.
Metformin + Remogliflozin Etabonate in other salts
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.14
Our Payment Partners